Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markley, H. G.
Right arrow Articles by Piepho, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markley, H. G.
Right arrow Articles by Piepho, R. W.
NEUROLOGY 1984;34:973
© 1984 American Academy of Neurology

Verapamil in prophylactic therapy of migraine

Herbert G. Markley, MD, John C.D. Cheronis, MD, PhD and Robert W. Piepho, PhD, FCP

From the Departments of Neurology (Dr Markley), Medicine (Dr. Cheronis), and the School of Pharmacy (Dr. Piepho). University of Colorado Health Sciences Center, Denver, CO.

We conducted a double-blind, placebo-controlled crossover study of verapamil HCI in the prophylaxis of chronic migraine headaches. Verapamil significantly reduced both headache frequency and duration with few side effects. The drug may be useful for a segment of the migraine population refractory to other prophylactic agents or for those who cannot tolerate the side effects of other drugs.

Address correspondence and reprint requests to Dr. Markley, Department of Neurology, Worcester Memorial Hospital, 119 Belmont St., Worcester, MA 01605.

Supported by General Clinical Research Centers Grant number RR00051-22 from the National Institutes of Health to the University of Colorado Health Sciences Center.

Presented in part at the thirty-fifth annual meeting of the American Academy of Neurology, San Diego, CA, April 1983.

Accepted for publication November 23, 1983.




This article has been cited by other articles:


Home page
NEJMHome page
K.M.A. Welch
Drug Therapy of Migraine
N. Engl. J. Med., November 11, 1993; 329(20): 1476 - 1483.
[Full Text]


Home page
Arch NeurolHome page
J. F. Rothrock, P. Walicke, M. R. Swenson, P. D. Lyden, and W. R. Logan
Migrainous Stroke
Arch Neurol, January 1, 1988; 45(1): 63 - 67.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. S. MEYER
Calcium Channel Blockers in the Prophylactic Treatment of Vascular Headache
Ann Intern Med, March 1, 1985; 102(3): 395 - 397.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.